Kutatási jelek – Signal Engine

• Three Versus 6 Months of Adjuvant Oxaliplatin‑Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial — Colorectal cancer
• Recent advancements in lung cancer research: a narrative review — NSCLC
• A prospective investigation of early‑onset colorectal cancer risk factors – pooled analysis of three large‑scale European cohorts — Colorectal cancer
• Small cell lung cancer – Trials in Disease – Overview of Information and Clinical Research — SCLC
• Adjuvant Quisinostat in High-Risk Uveal Melanoma - NCT06932757 — Melanoma
• Lung cancer in non-smokers — NSCLC
• Advances in Prostate Cancer Treatment: Exploring Molecular Targets and New Strategies in Castration-Resistant Disease — Prostate cancer
• KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials — Colorectal cancer
• Advancing breast, lung and prostate cancer research with federated learning. A systematic review — Breast cancer
• Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next — Prostate cancer
• Overcoming colorectal cancer and cancer stem cell resistance with photodynamic therapy: new frontiers in oncology — Colorectal cancer
• Gut Microbiome Alterations in Colorectal Cancer: Mechanisms, Therapeutic Strategies, and Precision Oncology Perspectives — Colorectal cancer
• Understanding prostate cancer care: recent progress and future direction — Prostate cancer
• Hope on the Horizon: Emerging Therapies for SCLC — SCLC
• Durable complete response of advanced hepatocellular carcinoma using cannabis oil: a report of two cases — Hepatocellular carcinoma
• Unlocking glioblastoma: breakthroughs in molecular mechanisms and next‑generation therapies — Glioblastoma
• A radio-genomics biomarker for precision epidermal growth factor receptor mutation targeting therapy in non‑small cell lung cancer — NSCLC
• Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‑Stratification, and Management — Leukemia
• Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single‑arm, open‑label, phase II clinical trial — Colorectal cancer
• A randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer — Colorectal cancer